Koninklijke Philips (RYLPF) Equity Income (2009 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Equity Income of $4.7 million in Q1 2026, up 144.7% quarter-over-quarter from -$10.5 million in Q4 2025, and up 545.2% on a YoY basis from $725819.5 in Q1 2025.
Koninklijke Philips (RYLPF) Equity Income (2009 - 2026) Analysis & Trends
Koninklijke Philips' Equity Income history runs 16 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Equity Income rose 545.2% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $10.3 million (down 33.45% YoY), while the FY2025 annual figure was -$10.5 million, up 92.09% from the prior year.
- Equity Income was $4.7 million for Q1 2026 at Koninklijke Philips, up from -$10.5 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of $127.4 million in Q3 2024 to a low of -$101.2 million in Q2 2024.
- Historically, Equity Income has averaged $9.9 million across 5 years, with a median of $2.2 million in 2024.
- Biggest YoY gain for Equity Income was 2693.46% in 2022; the steepest drop was 858.74% in 2022.
- A 5-year view of Equity Income shows it stood at -$87.7 million in 2022, then soared by 231.21% to $115.1 million in 2023, then tumbled by 108.35% to -$9.6 million in 2024, then decreased by 8.93% to -$10.5 million in 2025, then jumped by 144.7% to $4.7 million in 2026.
- The last three Equity Income figures came in at $4.7 million (Q1 2026), -$10.5 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.68 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.68 Mn |
| Dec 31, 2025 | -10.48 Mn |
| Sep 30, 2025 | 8.18 Mn |
| Jun 30, 2025 | 7.92 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Dec 31, 2024 | -9.62 Mn |
| Sep 30, 2024 | 127.39 Mn |
| Jun 30, 2024 | -101.23 Mn |
| Mar 31, 2024 | 2.17 Mn |
| Dec 31, 2023 | 115.13 Mn |
| Sep 30, 2023 | -20.68 Mn |
| Jun 30, 2023 | 67.51 Mn |
| Mar 31, 2023 | -17.17 Mn |
| Dec 31, 2022 | -87.74 Mn |
| Sep 30, 2022 | 91.75 Mn |
| Jun 30, 2022 | 4.27 Mn |
| Mar 31, 2022 | -12.35 Mn |
| Dec 31, 2021 | -9.15 Mn |
| Sep 30, 2021 | -3.54 Mn |
| Jun 30, 2021 | -7.23 Mn |